PATH
Seattle, Washington, United States
Purpose
to reduce the incidence and mortality of cervical cancer caused by human papillomavirus (HPV) infection by helping establish routine use of effective HPV-DNA screening tests in countries with high burdens of disease
Division
Global Development
Date
November 2013
Region Served
AFRICA, AMERICA
Committed amount
$10,000,000
Grant topic
Vaccine Delivery
Duration (months)
79
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.